Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular and intravenous infliximab for resistant seronegative oligoarthritis of the knee
2009-015810-23Phase 2Terminated
- Sponsor
- University of Leeds
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of infliximab in oligoarthritis (3 arms), sponsored by University of Leeds. Started Mar 2010; status: terminated.
02
Drugs
infliximab
03
Conditions
oligoarthritis
Beyond the preview
Go deeper on 2009-015810-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015810-23.